GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vistagen Therapeutics VTGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.18

+12.58%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Vistagen Therapeutics

Our reporting

We have not reported on Vistagen Therapeutics yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.37 a share.

Past results

Reported against what analysts expected

14 Aug 20266 Aug 202615 Jun 202612 Feb 202613 Nov 20257 Aug 2025
Earnings per share-0.30-0.47-0.37-0.45-0.54-0.47
Forecast-0.36-0.29-0.42-0.51-0.51-0.47
Revenue$1.5m——$303,000$258,000$244,000
Forecast$500,000——$364,433$145,800$215,670

Key events

  1. 7 Jun 202330-to-1 reverse split
  2. 14 Aug 201420-to-1 reverse split
  3. 10 Jun 20112-for-1 share split
  4. 18 Oct 2010Listed

Vistagen Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.